23.04.2019 • News

Trafigura and Altis Form Trading JV

Trafigura and Altis Form Trading JV (c) Tashatuvango/Shutterstock
Trafigura and Altis Form Trading JV (c) Tashatuvango/Shutterstock

Trafigura is forming a joint venture with US privately held trading and logistics company Altis Group International to create a commodity petrochemical trading business with a focus on bulk liquid chemicals.

The jv will comprise two entities –the existing Altis Group based in Houston, Texas, USA, and Altis International (Singapore), which will have a branch office in Geneva, Switzerland.

“We believe that the time is right to start exploring the potential of this market,” said Tom Jay, former head of Trafigura’s deals desk for refined metals, bulk and concentrates. He added that the petrochemicals market is expected to grow significantly over the next few years. Jay and Chris Clarkson, Trafigura’s head of gasoline trading, will join the boards of the new venture.

Jeff McNear, president of the Altis Group International management team, said the jv will accelerate Altis’ growth and ability to expand its trading reach globally.

Earlier this month, Trafigura announced it was to become the owner of major mining group Nyrstar.  The Geneva-based trading house is also partially funding a chemicals plant to be built by Finnish nickel and cobalt mining company Terrafame. The plant at Sotkamo, Finland, will produce chemicals for use in electric vehicle batteries, with commercial production expected to start in early 2021.

 

Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

most read